• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP MMT-723NAS; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP MMT-723NAS; PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR Back to Search Results
Model Number MMT-723NAS
Medical Device Problem Code Insufficient Flow or Under Infusion (2182)
Health Effect - Clinical Code Hyperglycemia (1905)
Date of Event 07/13/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).Currently it is unknown whether or not the device may have caused or contributed to the event as no product has been returned.The device will be returned for analysis and further information will follow once the analysis has been completed.No conclusion can be drawn at this time.
 
Event or Problem Description
The customer reported via phone call that they were in emergency room and were hospitalized for high blood glucose on (b)(6) 2020 with blood glucose level was 455 mg/dl, 450 mg/dl.Customer was treated with intravenous insulin.Customer had been using insulin pump system within 48 hours of reported high blood glucose event.Customer allege insulin pump was under delivering.Customer stated insulin pump was not working.Customer declined troubleshooting for high blood glucose level.The insulin pump will be returned for analysis and reservoir will not be returned for analysis.
 
Additional Manufacturer Narrative
Device passed the functional test, including the displacement test, rewind, basic occlusion test, occlusion test, prime/a33 test, excessive no delivery test and delivery accuracy test at 0.08745 inches.No under delivery anomaly or over delivery anomaly noted.The stop current and run current measurement tests are within specification.Device also passed self test, off no power alarm test and a21 error test.Device was monitored for 2 days.No unexpected battery power loss anomaly, blank display anomaly, unexpected low battery alarm or unexpected off no power alarm noted.Device uploaded properly using carelink.No cosmetic damage noted.The test p-cap and reservoir does lock in place in the reservoir compartment.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP MMT-723NAS
Common Device Name
PUMP, INFUSION, INSULIN, TO BE USED WITH INVASIVE GLUCOSE SENSOR
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
ceiba norte ind. park #50 road
juncos 00777 -386
MDR Report Key10348619
Report Number2032227-2020-155444
Device Sequence Number2432291
Product Code OYC
UDI-Device Identifier00643169693814
UDI-Public(01)00643169693814
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source consumer
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Model NumberMMT-723NAS
Device Catalogue NumberMMT-723NAS
Device Lot NumberB6723NASJ
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/05/2020
Initial Date Received by Manufacturer 07/25/2020
Supplement Date Received by Manufacturer08/10/2020
Initial Report FDA Received Date07/31/2020
Supplement Report FDA Received Date08/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
UNOMED INF SET
Outcome Attributed to Adverse Event Hospitalization;
Patient Age73 YR
Patient Weight117
-
-